May 22, 2007 - GE Healthcare today announced an important leadership change for one of the largest businesses within the company. Jim Davis has been promoted to the position of Vice President and General Manager of the company's Global Magnetic Resonance (MR) business. Davis replaces John Chiminski, who is now leading the integration of GE Healthcare’s acquisition of Abbott’s primary in vitro diagnostics businesses and Abbott Point-of-Care diagnostics businesses. Chiminski will lead GE’s new Clinical Diagnostics business following the closing of the acquisition.
The announcement was made at the 15th annual scientific meeting for the International Society for Magnetic Resonance in Medicine, in Berlin, Germany.
"I am looking forward to driving our market-leading MR business," said Davis. "GE Healthcare has incredible advances in MR imaging, including 3.0T SAR management, new approaches in cardiac imaging, applications that are improving breast diagnosis, and solutions for producing high-resolution MR images despite patient movement. I look forward to expanding these breakthrough technologies through strong customer partnerships and new breakthrough applications."
Davis began his professional career at GE in GE’s Aircraft Engines business in 1985 in GE’s Edison Engineering Program. He was vice president of Sales and Marketing for the Diagnostic Imaging Business in the America’s from January of 2001 through April of 2007.
June 12, 2026 
